NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Cardiol Therapeutics Inc. Class A Common Shares (NASDAQ: CRDL)

 
CRDL Technical Analysis
5
As on 9th Jun 2023 CRDL STOCK Price closed @ 0.75 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.34 & Strong Sell for SHORT-TERM with Stoploss of 1.80 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CRDLSTOCK Price

Open 0.68 Change Price %
High 0.83 1 Day 0.05 7.14
Low 0.67 1 Week 0.08 11.94
Close 0.75 1 Month 0.13 20.97
Volume 297700 1 Year -1.14 -60.32
52 Week High 2.31 | 52 Week Low 0.45
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
CRDL
Daily Charts
CRDL
Intraday Charts
Whats New @
Bazaartrend
CRDL
Free Analysis
 
CRDL Important Levels Intraday
RESISTANCE1.06
RESISTANCE0.96
RESISTANCE0.90
RESISTANCE0.84
SUPPORT0.66
SUPPORT0.60
SUPPORT0.54
SUPPORT0.44
 
CRDL Forecast April 2024
4th UP Forecast2.31
3rd UP Forecast1.81
2nd UP Forecast1.5
1st UP Forecast1.19
1st DOWN Forecast0.31
2nd DOWN Forecast0
3rd DOWN Forecast-0.31
4th DOWN Forecast-0.81
 
CRDL Weekly Forecast
4th UP Forecast1.31
3rd UP Forecast1.13
2nd UP Forecast1.02
1st UP Forecast0.91
1st DOWN Forecast0.59
2nd DOWN Forecast0.48
3rd DOWN Forecast0.37
4th DOWN Forecast0.19
 
CRDL Forecast2024
4th UP Forecast4.43
3rd UP Forecast3.25
2nd UP Forecast2.52
1st UP Forecast1.79
1st DOWN Forecast-0.29
2nd DOWN Forecast-1.02
3rd DOWN Forecast-1.75
4th DOWN Forecast-2.93
 
 
CRDL Other Details
Segment EQ
Market Capital 157996240.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
CRDL Address
CRDL
 
CRDL Latest News
 
Your Comments and Response on Cardiol Therapeutics Inc. Class A Common Shares
 
CRDL Business Profile
Cardiol Therapeutics Inc., a clinical-stage biotechnology company, focuses on the research and development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, an ultra-pure and high concentration cannabidiol oral formulation for the treatment of in hospitalized COVID-19 patients with a prior history of risk factors for CVD; and has completed phase I clinical trials for the treatment of acute myocarditis and other inflammatory heart disease. The company is also developing a proprietary subcutaneous formulation of cannabidiol to achieve higher bioavailability for the treatment chronic heart failure. In addition, it develops proprietary nanotechnology to enable the distribution of water insoluble drugs within the blood circulation, enhance pharmacokinetics, and facilitate drug accumulation in the failing heart. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada. Address: 2265 Upper Middle Road East, Oakville, ON, Canada, L6H 0G5
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service